Published in Biomater Sci on October 15, 2014
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans. Int J Nanomedicine (2016) 0.75
The interaction of fluorescent nanodiamond probes with cellular media. Mikrochim Acta (2017) 0.75
Determining the Effective Density and Stabilizer Layer Thickness of Sterically Stabilized Nanoparticles. Macromolecules (2016) 0.75
Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol (2006) 2.35
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci (2011) 2.13
Antibacterial properties of nanoparticles. Trends Biotechnol (2012) 2.11
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One (2011) 1.77
The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68
Hedgehog signalling as an antagonist of ageing and its associated diseases. Bioessays (2012) 1.50
Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm (2007) 1.46
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev (2011) 1.40
Graphene: promises, facts, opportunities, and challenges in nanomedicine. Chem Rev (2013) 1.28
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv (2014) 1.26
Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest (2010) 1.20
Optical sensor arrays for chemical sensing: the optoelectronic nose. Chem Soc Rev (2013) 1.17
Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther (2006) 1.16
Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision". PLoS One (2012) 1.13
Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. Eur J Pharm Biopharm (2009) 1.13
A phospholipidomic analysis of all defined human plasma lipoproteins. Sci Rep (2011) 1.07
Characterization of coagulation factor synthesis in nine human primary cell types. Sci Rep (2012) 1.06
Protein corona significantly reduces active targeting yield. Chem Commun (Camb) (2013) 1.05
Response to "Platelets proteomics in transfusion medicine: a reality with challenging but promising future". Blood Transfus (2012) 1.05
Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta (2007) 1.04
Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res (2006) 1.01
Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest (2011) 1.00
Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chem Rev (2012) 1.00
Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease. Sci Rep (2013) 1.00
In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardium. Eur Heart J (2009) 0.99
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology (2011) 0.98
Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin. ChemMedChem (2009) 0.96
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials (2009) 0.96
Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies--a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans Nanobioscience (2007) 0.95
Exocytosis of nanoparticles from cells: role in cellular retention and toxicity. Adv Colloid Interface Sci (2013) 0.94
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int J Nanomedicine (2011) 0.93
Effects of magnetite nanoparticles on soybean chlorophyll. Environ Sci Technol (2013) 0.92
Cell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticles. Sci Rep (2012) 0.91
Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater (2012) 0.91
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet (2011) 0.90
Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine (Lond) (2012) 0.89
Particle size distribution measurements of manganese-doped ZnS nanoparticles. Anal Chem (2009) 0.87
Big signals from small particles: regulation of cell signaling pathways by nanoparticles. Chem Rev (2013) 0.87
Human plasma very low density lipoprotein carries Indian hedgehog. J Proteome Res (2010) 0.87
SELDI-TOF mass spectrometry of High-Density Lipoprotein. Proteome Sci (2007) 0.86
A fast and reproducible method to quantify magnetic nanoparticle biodistribution. Analyst (2014) 0.86
Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale (2013) 0.86
Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery. J Microencapsul (2008) 0.85
Solder doped polycaprolactone scaffold enables reproducible laser tissue soldering. Lasers Surg Med (2008) 0.85
Significance of cell "observer" and protein source in nanobiosciences. J Colloid Interface Sci (2012) 0.84
Graphene oxide strongly inhibits amyloid beta fibrillation. Nanoscale (2012) 0.84
Hard corona composition and cellular toxicities of the graphene sheets. Colloids Surf B Biointerfaces (2013) 0.84
Superparamagnetic nanoparticles - a tool for early diagnostics. Swiss Med Wkly (2010) 0.83
Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol (2012) 0.83
Systemic distribution and elimination of plain and with Cy3.5 functionalized poly(vinyl alcohol) coated superparamagnetic maghemite nanoparticles after intraarticular injection in sheep in vivo. J Nanosci Nanotechnol (2006) 0.83
Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. Nanoscale (2010) 0.83
Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Nanoscale (2014) 0.83
Dielectrophoresis-based particle exchanger for the manipulation and surface functionalization of particles. Lab Chip (2007) 0.82
Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomedicine (Lond) (2015) 0.82
Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field. Chem Commun (Camb) (2012) 0.82
Use of seeds to control precipitation of calcium carbonate and determination of seed nature. Langmuir (2005) 0.82
Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res Ther (2014) 0.82
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Int J Hyperthermia (2009) 0.81
Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale (2015) 0.81
Uptake and biocompatibility of functionalized poly(vinylalcohol) coated superparamagnetic maghemite nanoparticles by synoviocytes in vitro. J Nanosci Nanotechnol (2006) 0.81
A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation. PLoS One (2013) 0.80
Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo. Small (2014) 0.80
Superparamagnetic nanoparticles as a powerful systems biology characterization tool in the physiological context. Angew Chem Int Ed Engl (2008) 0.80
Regulation of stem cell fate by nanomaterial substrates. Nanomedicine (Lond) (2015) 0.79
Protein diffusion through charged nanopores with different radii at low ionic strength. Phys Chem Chem Phys (2014) 0.79
Formation and drying of colloidal crystals using nanosized silica particles. Langmuir (2006) 0.79
Engineering the nanoparticle-protein interface for cancer therapeutics. Cancer Treat Res (2015) 0.79
In-situ electrical addressing of one-dimensional gold nanoparticle assemblies. J Nanosci Nanotechnol (2008) 0.79
Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process. Nanoscale (2015) 0.79
Synthesis of pseudopolyrotaxanes-coated Superparamagnetic Iron Oxide Nanoparticles as new MRI contrast agent. Colloids Surf B Biointerfaces (2012) 0.79
A single-cell correlative nanoelectromechanosensing approach to detect cancerous transformation: monitoring the function of F-actin microfilaments in the modulation of the ion channel activity. Nanoscale (2015) 0.78
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles. ACS Chem Neurosci (2012) 0.78
Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model. Environ Health Perspect (2015) 0.77
Visible light optical coherence correlation spectroscopy. Opt Express (2014) 0.77
Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. J Biomed Nanotechnol (2015) 0.77
Synthesis of new hybrid nanomaterials: promising systems for cancer therapy. Nanomedicine (2011) 0.76
Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles. Bioconjug Chem (2007) 0.76
Dichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaques. Mol Med (2012) 0.76
Evaluation of radiogallium-labeled, folate-embedded superparamagnetic nanoparticles in fibrosarcoma-bearing mice. J Cancer Res Ther (2012) 0.76
Protein fibrillation and the olfactory system: speculations on their linkage. Trends Biotechnol (2012) 0.75
Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl Mater Interfaces (2013) 0.75
Micropatterned nanostructures: a bioengineered approach to mass-produce functional myocardial grafts. Nanotechnology (2015) 0.75
Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs). J Aerosol Med Pulm Drug Deliv (2014) 0.75
Cell-imprinted substrates act as an artificial niche for skin regeneration. ACS Appl Mater Interfaces (2014) 0.75
Methods of protein corona isolation for magnetic nanoparticles. Analyst (2017) 0.75
Control of morphology and nanostructure of copper and cobalt oxalates: effect of complexing ions, polymeric additives and molecular weight. Nanoscale (2010) 0.75
Determination of nanoparticles using UV-Vis spectra. Nanoscale (2015) 0.75